Financial Statements

Bayer Group Consolidated Statements of Cash Flows

[Table 4.4]
Note 2012 2013
€ million € million
Income after income taxes 2,453 3,186
Income taxes 723 1,021
Financial result 752 727
Income taxes paid or accrued (1,560) (1,644)
Depreciation, amortization and impairments 2,988 2,896
Change in pension provisions (581) (249)
(Gains) losses on retirements of noncurrent assets (219) (105)
Gross cash flow 4,556 5,832
Decrease (increase) in inventories (680) (608)
Decrease (increase) in trade accounts receivable (455) (751)
(Decrease) increase in trade accounts payable 550 389
Changes in other working capital, other non-cash items 559 309
Net cash provided by (used in) operating activities (net cash flow) [33] 4,530 5,171
Cash outflows for additions to property, plant, equipment and intangible assets (1,929) (2,157)
Cash inflows from sales of property, plant, equipment and other assets 230 153
Cash inflows from divestitures 178 79
Cash inflows from (outflows for) noncurrent financial assets (258) 204
Cash outflows for acquisitions less acquired cash (466) (1,082)
Interest and dividends received 104 125
Cash inflows from (outflows for) current financial assets 1,327 97
Net cash provided by (used in) investing activities [34] (814) (2,581)
Dividend payments and withholding tax on dividends (1,366) (1,574)
Issuances of debt 1,308 9,078
Retirements of debt (3,254) (9,697)
Interest paid including interest rate swaps (793) (550)
Interest received from interest rate swaps 325 212
Cash outflows for the purchase of additional interests in subsidiaries (3) (4)
Net cash provided by (used in) financing activities [35] (3,783) (2,535)
Change in cash and cash equivalents due to business activities (67) 55
Cash and cash equivalents at beginning of year 1,771 1,698
Change in cash and cash equivalents due to changes in scope of consolidation
Change in cash and cash equivalents due to exchange rate movements (6) (91)
Cash and cash equivalents at end of year   1,698 1,662
2012 figures restated
Last updated: February 28, 2014  Copyright © Bayer AG
http://www.annualreport2013.bayer.com